SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-22-000122
Filing Date
2022-12-12
Accepted
2022-12-12 17:04:23
Documents
12
Period of Report
2022-12-12
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K isee-20221212.htm   iXBRL 8-K 36015
  Complete submission text file 0001410939-22-000122.txt   170657

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20221212.xsd EX-101.SCH 1921
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20221212_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20221212_pre.xml EX-101.PRE 12525
6 EXTRACTED XBRL INSTANCE DOCUMENT isee-20221212_htm.xml XML 10555
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 221457809
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences